Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYALURONIDASE RECOMBINANT HUMAN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

32.9%
Female
67.1%
Male

Age Information

The average age of patients reporting adverse events with HYALURONIDASE RECOMBINANT HUMAN is 65.3 years.

Geographic Distribution

The majority of adverse event reports for HYALURONIDASE RECOMBINANT HUMAN originate from US.

Report Summary & Outcomes

47
Total Reports
47
As Primary/Secondary Suspect
7
Deaths Reported
44
Hospitalizations
8
Life-Threatening
3
Disabilities

Reporting Timeline

First adverse event report: 20130705. Most recent report: 20160417. View full timeline →

More About HYALURONIDASE RECOMBINANT HUMAN

HYALURONIDASE RECOMBINANT HUMAN Full Profile Reports by Year Drug Interactions